Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-17 @ 7:01 AM
Study NCT ID:
NCT02877667
Status:
COMPLETED
Last Update Posted:
2020-07-29
First Post:
2016-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol
Sponsor:
Soliton
Organization:
Study Overview
Official Title:
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SOL1601
Brief Summary:
Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.
Detailed Description:
A non-significant risk, single center, prospective device trial to evaluate the number of passes of Q-Switch laser treatment that can be completed with a Q-Switch Laser alone compared to use of the Soliton Planar Acoustic Wave Device System (AWD) System as an accessory to Q-switched laser in tattoo reduction treatment.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: